![]() |
|
A. Delluc (1), L. Gourhant (2), K. Lacut (2), B. Mercier (3), M.-P. Audrezet (3), E. Nowak (2), E. Oger (1), C. Leroyer (1), D. Mottier (1), G. Le Gal (1), F. Couturaud (1)
(1) Université Européeenne de Bretagne, Université de Brest, EA3878, IFR 148, Brest, and Département de médecine interne et de pneumologie, CHU de la Cavale Blanche, Brest, France; (2) Université Européenne de Bretagne, Université de Brest, INSERM CIC 05–02, IFR148 and CHU de la Cavale Blanche, Brest, France; (3) Université Européenne de Bretagne, Université de Brest, INSERM U613, IFR148 and Laboratoire de génétique moléculaire, CHU Morvan, Brest, France
Venous thromboembolism (VTE) is a multifactorial disease, caused by interacting environmental and genetic risk factors. Gene-centric genotyping strategy is one of the approaches to explore unexplained associations between risk factors and VTE. It was the objective of this study to evaluate, using a gene-centric genotyping strategy, polymorphisms in genes involved in the following pathways: coagulation cascade process, renin-angiotensin or adrenergic systems, lipid metabolism, platelet aggregation. Allele frequency was compared between 677 cases with idiopathic VTE and their matched controls. After Bonferroni adjustment, four single nucleotide polymorphisms (SNPs) were significantly associated with VTE: Factor XI rs925451 polymorphism, factor XI rs2289252 polymorphism, factor II rs1799963 (G20210A) polymorphism and factor V Leiden rs6025. An additive mode of inheritance fitted best both factor XI polymorphisms. In this hospital-based case-control study, two polymorphisms located on the factor XI gene were significantly associated with VTE. Other newly investigated polymorphisms with potentially false negatives may warrant further analyses.
Venous thrombosis, gene mutations, Factor XI
| 1. | ||
Elena Rossi, Tommaso Za, Angela Ciminello, Giuseppe Leone, Valerio De Stefano Thrombosis and Haemostasis 2008 99 6: 1030-1034 http://dx.doi.org/10.1160/TH08-02-0069 | ||
| 2. | ||
Anja J. M. Schreijer1,2, Suzanne C. Cannegieter1, Marianna Caramella3, Joost C. M. Meijers2, Raymond T. Krediet4, Ries M. Simons5, Frits R. Rosendaal1,6,7 Thrombosis and Haemostasis 2008 99 6: 1053-1059 http://dx.doi.org/10.1160/TH07-11-0681 | ||
| 3. | ||
Robert L. Levine1, Jacques R. LeClerc2, Joan E. Bailey3, Matthew J. Monberg4, Samiha Sarwat5 Thrombosis and Haemostasis 2008 99 5: 892-898 http://dx.doi.org/10.1160/TH08-01-0004 | ||